Skip to main content
. 2023 May 2;66(3):E219–E227. doi: 10.1503/cjs.019420

Table 4.

Multivariate analyses for overall, disease-free and progression-free survival*

Variable Overall survival Disease-free survival Progression-free survival



HR (95% CI) p value HR (95% CI) p value HR (95% CI) p value
Age, yr 0.993 (0.979–1.007) 0.31 1.022 (0.994–1.051) 0.12 1.002 (0.979–1.025) 0.90

Female v. male sex 1.066 (0.748–1.520) 0.72 0.751 (0.379–1.489) 0.41 1.306 (0.779–2.190) 0.31

Locally advanced v. early stage 3.291 (1.887–5.738) < 0.001 4.313 (1.813–10.259) < 0.001

Rural or remote v. urban or suburban residence 0.622 (0.383–1.010) 0.06 0.472 (0.186–1.200) 0.12 0.536 (0.250–1.149) 0.11

CI = confidence interval; HR = hazard ratio.

*

Clinical variables with a statistically significant difference between groups in univariate analysis were included in this model.

Not applicable for progression-free survival since all patients had locally advanced cancer.